Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 3Warts 2Keratosis, Actinic 2Hyperthermia 2Hematologic Neoplasms 2Hemangioma 2Squamous Intraepithelial Lesions 1Skin Neoplasms 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pituitary Neoplasms 1Pelvic Neoplasms 1Pain 1Obesity 1Nonmelanoma Skin Cancers 1Mucositis 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Melanoma 1Kidney Neoplasms 1Invasive Fungal Infections 1Insulinoma 1Infertility, Female 1Infertility 1Inappropriate Prescribing 1Hyperinsulinism 1Hemorrhage 1Head and Neck Carcinoma 1

Interventions

Standard of Care 5Practice Guidelines as Topic 5Magnetic Resonance Spectroscopy 2pembrolizumab 1X-Rays 1Surgery, Computer-Assisted 1Solutions 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Neurofeedback 1Monitoring, Physiologic 1Interviews as Topic 1Indocyanine Green 1Docetaxel 1DEAE-Dextran 1Counseling 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Head and Neck Carcinoma × Solutions × Clear all
NCT03745690 2022-03-17

Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer

Jonsson Comprehensive Cancer Center

Phase 1/2 Withdrawn
Head & Neck

Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡